Field Medical’s FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.

CARDIFF-BY-THE-SEA, Calif., Dec. 5, 2024 /PRNewswire/ — Field Medical® Inc., a leader in pulsed field cardiac catheter ablation technology, announced today that its FieldForce™ Ablation System has been accepted into the FDA’s Total Product Life Cycle Advisory Program (TAP) Pilot and granted Breakthrough Device Designation for sustained monomorphic scar-related ventricular tachycardia (VT). This recognition underscores the […] L'articolo Field Medical’s FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia. proviene da La Ragione.

CONTINUA A LEGGERE